Showing results (151-160 of 770) with videos related to
Sort By:
Pageof 77
Journal of Drugs in Dermatology : JDD|July 8, 2017
Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: A Safe and Effective Acne Therapy in All Skin PhototypesAndrew F Alexis, Fran E Cook-Bolden, J P YorkPharmaceutical Development and Technology|May 8, 1999
Scaleup of a pharmaceutical granulation in planetary mixersM Landín, P York, M J Cliff, et al.Cellular Immunology|March 1, 1983
Specific and nonspecific T-cell recruitment in viral meningitis: possible implications for autoimmunityJ L Hurwitz, R Korngold, P C DohertyInfection and Immunity|November 1, 1982
Capacity of influenza virus-monoclonal antibody mixtures to stimulate memory and cytotoxic T lymphocyte populationsN Greenspan, J L Hurwitz, P C DohertyThe Journal of Experimental Medicine|December 1, 1977
The control of specificity of cytotoxic T lymphocytes by the major histocompatibility complex (AG-B) in rats and identification of a new alloantigen system showing no AG-B restrictionA Marshak, P C Doherty, D B WilsonJournal of Immunology (Baltimore, Md. : 1950)|July 1, 1981
Early dominance of irradiated host cells in the responder profiles of thymocytes from P leads to F1 radiation chimerasR Korngold, J R Bennink, P C DohertyJournal of Immunology (Baltimore, Md. : 1950)|March 20, 2001
Diversity of epitope and cytokine profiles for primary and secondary influenza a virus-specific CD8+ T cell responsesG T Belz, W Xie, P C DohertyPhysical Review Letters|August 23, 2002
Photon statistics and dynamics of fluorescence resonance energy transferAndrew J Berglund, Andrew C Doherty, Hideo MabuchiImmunology|April 1, 1989
In vivo treatment with an appropriate anti-Thy-1.2 monoclonal antibody abrogates hybrid resistance to Thy-1.1+ virus-immune effector T cellsP C Doherty, J E Allan, W AllanPharmaceutical Research|August 4, 1998
Characterisation of the glass transition of an amorphous drug using modulated DSCP G Royall, D Q Craig, C DohertyPageof 77